PMID: 7329822Jan 1, 1981

Arginine vasotocin: effects on open field behavior, whole brain monoamines and plasma corticosterone

P Golus, M G King


Two experiments were performed to evaluate the effects of Arginine Vasotocin (AVT) on open field behavior, who brain monoamines and plasma corticosterone. In Experiment 1 rats treated with AVT compared to controls displayed an increased initial latency to move, less postural freezing and increased exploration of the central area of the open field. In Experiment 2 it was found that AVT significantly elevated whole brain 5-HT levels (Experiment 2A) without altering levels of dopamine or norepinephrine. Plasma corticosterone was significantly decreased by AVT treatment (Experiment 2B).


Apr 1, 1979·Physiology & Behavior·R A Hicks, J D Moore
May 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·R WalterD de Wied
Jan 1, 1979·Progress in Brain Research·S Pavel
Dec 4, 1978·Life Sciences·H J Romijn
Sep 1, 1979·Pharmacology, Biochemistry, and Behavior·P GolusM G King
Apr 1, 1977·Pharmacology, Biochemistry, and Behavior·P C Datta, M G King
Jul 1, 1972·Acta Endocrinologica·K L Dickson, D L Hasty
Jan 1, 1973·Neuroendocrinology·S PavelM Petrescu
May 1, 1971·Australian and New Zealand Journal of Medicine·H Hinterberger
Jun 1, 1968·General and Comparative Endocrinology·G A KinsonL Grant
Dec 1, 1981·Pharmacology, Biochemistry, and Behavior·P Golus, M G King
Feb 1, 1957·British Journal of Psychology·P L BROADHURST

Related Concepts

Norepinephrine, (+, -)-Isomer
Dopamine Measurement
Norepinephrine Measurement

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.